Universal Biosensors Inc (UBI) is a global biosensor company and a world leader in electrochemical cell technology. With a focus on utilizing its patented biosensor technology, UBI aims to develop a diverse range of biosensor test strips used in their hand-held portable analyzers. These test strips enable cost-effective, effortless, and accurate detection of analytes of interest across various industries, including human health, animal health, environmental, and agriculture.

Headquartered in Melbourne, Australia, UBI operates a state-of-the-art manufacturing facility and research laboratory. The company is listed on the Australian Securities Exchange (ASX:UBI) as a USA Delaware company. UBI has successfully launched groundbreaking products like the Sentia™ handheld wine analyzer, which measures free SO2, malic acid, and glucose in the wine production process.

They have also introduced Xprecia Prime™, the next-generation blood coagulation analyzer, and are set to launch Petrackr™, a veterinary blood glucometer for monitoring diabetes in cats and dogs. As an innovative leader in biosensor technology, UBI continues to develop new products and solutions that revolutionize the industry